Company Performance Metrics
James Timourian: President- Patricia Nadworny: Quality and Safety Director
Innovotech solves client biofilm problems through its Biofilm Contract Research Department. The company has a distinguished track record of both standardized and customized research to meet client needs.
The scope of research is from early stage identification of problems and screening of agents for "anti-biofilm activity", to research
acceptable to regulatory agencies for product claim validation, to post-market product comparisons for marketing purposes. The company regularly develops in vitro models of the client specific situation as a starting point that enables any number of test parameters to be tested.
Most of Innovotech's R&D has grown out of work with the MBEC™ and BEST™ assays. From these platforms, Innovotech has developed a number of unique methods for testing antimicrobial agents in solution and coated onto a large variety of surfaces that can appear in medical, dental, agricultural or industrial settings.
Innovotech also combines the use of these basic platforms with internal expertise in diverse areas such as biofilms, medical devices and silver chemistry, to develop its own lines of anti-biofilm agents for various applications. The InnovoSIL™ family shows promise for use in medical devices, and Agress® has demonstrated effectiveness when tested for agricultural applications.
